About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 454 trials

RecruitingThe COSMYC Trial (COmbined Suppression of MYC)This research is being done to determine if receiving the combination of testosterone and ZEN-3694 followed by the combination of enzalutamide plus ZEN-3694 will decrease the size…NCT06922318·Baltimore, Maryland RecruitingSPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationThe investigators will study SPECT imaging of radiopharmaceutical therapies given as standard of care or as part of other compatible research protocols.NCT06389097·Baltimore, Maryland TerminatedDocetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate CancerThis randomized phase II trial studies how well docetaxel works when given with or without ascorbic acid in treating patients with prostate cancer that has spread to other places…NCT02516670·Washington D.C., District of Columbia and 5 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Multicenter, open-label, phase 1, cohort dose escalation study to determine the Maximum Tolerated Dose (MTD) of OSI-906 in combination with erlotinibNCT00739453·Aurora, Colorado and 3 others

CompletedTesting the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate GlandApalutamide is an anti-androgen that blocks the effect of testosterone on prostate cancer growth.NCT04530552·Tucson, Arizona and 4 others

UnknownASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing TaxotereThe purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.NCT00043576·Montgomery, Alabama and 61 others

CompletedMagnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerRATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate…NCT00032058·San Francisco, California and 7 others

RecruitingImage-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTThe Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients…NCT03861676·Baltimore, Maryland

CompletedSurvivorship Promotion In Reducing IGF-1 TrialThis is a prospective, single-center randomized trial with three arms, and an allocation ratio of 1:1:1.NCT02431676·Baltimore, Maryland

CompletedBN83495 in Prostate CancerThe purpose of the study is to evaluate the pharmacodynamic profile and safety of BN83495 in patients with prostate cancer with disease progression while on androgen ablative…NCT00790374·Baltimore, Maryland and 2 others

Active not recruitingMRI for Assessing Prostate Cancer ResponseProstate cancer is one of most common cancers in America, affecting 1 in 6 men. External beam radiation therapy is one of the common methods to treat prostate cancer.NCT01607008·Baltimore, Maryland

RecruitingTrial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate CancerTo determine if dexamethasone or dexamethasone plus metronidazole restore sensitivity to abiraterone for the treatment of metastatic prostate cancer.NCT06616597·Baltimore, Maryland

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

Active not recruitingPYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerThe purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the…NCT06074510·Birmingham, Alabama and 13 others

UnknownDecision Navigation for Advanced Prostate Cancer Treatment Options Using mHealthProstate cancer is a commonly diagnosed cancer, and is the second leading cause of cancer deaths among men in the U.S. The subgroup of men with advanced prostate cancer is…NCT03327103·Baltimore, Maryland and 2 others

UnknownClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue EvaluationThe purpose of this study is to demonstrate the effectiveness and safety of the ClariCore System in obtaining prostate biopsies with device feedback that provides real-time tissue…NCT03504761·Denver, Colorado and 5 others

Active not recruitingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialThis phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer…NCT04513717·Fairbanks, Alaska and 601 others

TerminatedDocetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerThis randomized phase II trial studies how well docetaxel and prednisone with or without vaccine therapy works in treating patients with hormone-resistant prostate cancer that has…NCT01145508·Jacksonville, Florida and 13 others

CompletedProstate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic…NCT00106691·Huntsville, Alabama and 137 others

Active not recruitingLong-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® TestingThis registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing.NCT04404894·Homewood, Alabama and 6 others

PreviousPage 4 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma